Becton Dickinson And Company  (BDX)
Other Ticker:  

Becton Dickinson And Company Segments

Medical Surgical Systems
   48.33 % of total Revenue
Diabetes Care
   8.45 % of total Revenue
Pharmaceutical Systems
   11.48 % of total Revenue
Medical Total
   68.25 % of total Revenue
Preanalytical Systems
   12.03 % of total Revenue
Diagnostic Systems
   10.41 % of total Revenue
Diagnostics Total
   31.75 % of total Revenue
Immunocytometry Systems
   9.27 % of total Revenue

Business Segments (June 30. 2015)
(in millions $)
III. Quarter
(of total Revenues)
(June 30. 2015)
(in millions $)
III. Quarter
(Profit Margin)
Medical Surgical Systems
1,402.00 48.33 % 0.00 -
Diabetes Care
245.00 8.45 % 0.00 -
Pharmaceutical Systems
333.00 11.48 % 0.00 -
Medical Total
1,980.00 68.25 % 483.00 24.39 %
Preanalytical Systems
349.00 12.03 % 0.00 -
Diagnostic Systems
302.00 10.41 % 0.00 -
Diagnostics Total
921.00 31.75 % 0.00 -
Immunocytometry Systems
269.00 9.27 % 0.00 -
2,901.00 100 % 680.00 23.44 %

• View Income Statement • View Competition by Segment • View Annual Report

Growth rates by Segment (June 30. 2015)
Y/Y Revenue
III. Quarter
Q/Q Revenue
(June 30. 2015)
Y/Y Income
III. Quarter
Q/Q Income
Medical Surgical Systems
137.63 % 148.14 % - -
Diabetes Care
-5.04 % -0.81 % - -
Pharmaceutical Systems
-5.67 % 13.27 % - -
Medical Total
64.86 % 79.02 % 35.67 % 47.26 %
Preanalytical Systems
-4.12 % 2.95 % - -
Diagnostic Systems
-4.13 % -5.03 % - -
Diagnostics Total
35.64 % 40.18 % - -
Immunocytometry Systems
-2.89 % -6.92 % - -
34.49 % 41.37 % -13.71 % 28.79 %

• View Growth rates • View Competitors Segment Growth • View Market Share

To get more information on Becton Dickinson's Medical Surgical Systems, Diabetes Care, Pharmaceutical Systems, Medical Total, Preanalytical Systems, Diagnostic Systems, Diagnostics Total, Immunocytometry Systems, Total segment. Select each division with the arrow.

  Becton Dickinson's

Business Segments Description

BD Medical

The major products in this segment are hypodermic syringes and needles for injection, insulin syringes and pen needles and blood glucose monitoring systems for diabetes care, infusion therapy devices, prefillable drug delivery systems and surgical blades and scalpels. This segment also includes specialty blades and cannulas for ophthalmic surgery procedures, anesthesia needles, critical care systems, elastic support products and thermometers.

BD Diagnostics

The major products in this segment are clinical and industrial microbiology products, sample collection products, specimen management systems, molecular diagnostic instruments and other diagnostic systems, including immunodiagnostic test kits. This segment also includes consulting services.

BD Biosciences

This segment provides integrated systems, products and services for a variety of applications in life sciences. The major products are flow cytometry systems for cell analysis, monoclonal antibodies for biomedical research, molecular biology products for the study of genes and their functions, cell growth and screening products, and labware products.


BD's products are manufactured and sold worldwide. The principal markets for BD's products outside the United States are Europe, Japan, Asia Pacific, Canada and Latin America. The principal products sold by BD outside of the United States are hypodermic needles and syringes, insulin syringes and pen needles, diagnostic systems, VACUTAINER'r' brand blood collection products, HYPAK'r' brand prefillable syringe systems, and infusion therapy products. BD has manufacturing operations outside the United States in Brazil, China, France, Germany, India, Ireland, Japan, Korea, Mexico, Pakistan, Singapore, Spain, Sweden and the United Kingdom.


Sales by Geography Competition By Business Segments Company Profile

Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production


Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales


Event Calendar

PBH's Profile

Stock Price

PBH's Financials

Business Description


Charts & Quotes

PBH's News


PBH's Competitors

Customers & Markets

Economic Indicators

PBH's Growth

Company Segments


Stock Performance

Growth Rates




Financial Strength


Largest Companies

Management Effectivness


At a Glance


Growth Rates



Financial Strength


At a Glance



Sectors & Industries






About us


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071